Literature DB >> 30044646

Quality by design (QbD) approaches in current pharmaceutical set-up.

Vijay Mishra1, Sourav Thakur1, Akshay Patil1, Anshuman Shukla2.   

Abstract

INTRODUCTION: Quality by design (QbD) encourages the pharmaceutical industry to use risk management and science-based manufacturing principles to gain process and product understanding and thus assures quality of the product. With the objective to curb the rising costs for development and regulatory barriers to innovation and creativity, QbD is being widely promoted by Food and Drug Administration (FDA) and International Conference on Harmonization (ICH). AREAS COVERED: This review describes the elements, different design and tools of QbD as well as multidimensional applications of QbD ranging from dosage form and method development to meeting latest regulatory requirements. EXPERT OPINION: The understanding of a process is facilitated by proper identification of sources of variation, management of variability by process design, and prediction of product quality attributes using design space. The pharmaceutical industry is rapidly adopting the QbD principles for fabrication of safe, effective and quality products; however, we are still on a journey and the process of gathering all experience and metrics required for connecting and demonstrating QbD benefits to all stakeholders is still in progress. Understanding the formulation and process parameters with the philosophy of QbD will be useful for the optimization of complex drug delivery systems in the near future.

Entities:  

Keywords:  Quality by design; drug delivery system; nanocarrier; process design; product design; risk management

Mesh:

Substances:

Year:  2018        PMID: 30044646     DOI: 10.1080/17425247.2018.1504768

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  10 in total

Review 1.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

Review 2.  Benefits of Fractal Approaches in Solid Dosage Form Development.

Authors:  Renata Abreu-Villela; Martin Kuentz; Isidoro Caraballo
Journal:  Pharm Res       Date:  2019-09-06       Impact factor: 4.200

Review 3.  Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.

Authors:  Anitha Sriram; Suma Tangirala; Srividya Atmakuri; Sajid Hoque; Sheela Modani; Saurabh Srivastava; Srushti Mahajan; Indrani Maji; Rahul Kumar; Dharmendra Khatri; Jitender Madan; Pankaj Kumar Singh
Journal:  AAPS PharmSciTech       Date:  2021-11-03       Impact factor: 3.246

Review 4.  Current approaches of nanomedicines in the market and various stage of clinical translation.

Authors:  Xiaoting Shan; Xiang Gong; Jie Li; Jingyuan Wen; Yaping Li; Zhiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2022-03-01       Impact factor: 14.903

Review 5.  Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

Authors:  Arun Butreddy; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2020-11-28       Impact factor: 4.384

Review 6.  Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch.

Authors:  Josip Matić; Amrit Paudel; Hannes Bauer; Raymar Andreina Lara Garcia; Kinga Biedrzycka; Johannes G Khinast
Journal:  AAPS PharmSciTech       Date:  2020-06-22       Impact factor: 3.246

7.  Niosomal Nanocarriers for Enhanced Dermal Delivery of Epigallocatechin Gallate for Protection against Oxidative Stress of the Skin.

Authors:  Danhui Li; Nataly Martini; Zimei Wu; Shuo Chen; James Robert Falconer; Michelle Locke; Zhiwen Zhang; Jingyuan Wen
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 8.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

9.  Towards predicting the product quality in hot-melt extrusion: Pilot plant scale extrusion.

Authors:  Josip Matić; Carolina Alva; Simone Eder; Kathrin Reusch; Amrit Paudel; Johannes Khinast
Journal:  Int J Pharm X       Date:  2021-06-06

10.  Analysis of Issues and Future Trends Impacting Drug Safety in South Korea.

Authors:  Myeong Gyu Kim; Seungyeon Huh; Nayoung Han; Jae Hyun Kim; Kyungim Kim; Euni Lee; In-Wha Kim; Jung Mi Oh
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.